Kh. Astrin et Rj. Desnick, MOLECULAR-BASIS OF ACUTE INTERMITTENT PORPHYRIA - MUTATIONS AND POLYMORPHISMS IN THE HUMAN HYDROXYMETHYLBILANE SYNTHASE GENE, Human mutation, 4(4), 1994, pp. 243-252
Acute intermittent porphyria (AIP) is an autosomal dominant inborn err
or of metabolism that results from the half normal activity of the thi
rd enzyme in the heme biosynthetic pathway, hydroxymethylbilane syntha
se (HMB-synthase). AIP is an ecogenetic condition, with life-threateni
ng acute attacks precipitated by various factors including drugs, alco
hol, fasting, and certain hormones. Biochemical diagnosis is problemat
ic and the identification of mutations in the HMB synthase gene provid
es ac curate detection of presymptomatic heterozygotes, permitting avo
idance of the acute precipitating factors. Two HMB synthase isozymes a
re encoded by the HMB synthase gene: one unique to erythroid cells and
the other a housekeeping isozyme present in all cells. These two isoz
ymes arise from a single gene by alternative splicing. The recent isol
ation of the cDNAs and entire genomic sequence encoding the HMB syntha
se isozymes has facilitated the detection of diagnostically useful int
ragenic polymorphisms and disease-causing mutations, Of the 36 mutatio
ns identified to date, most caused the classic form of AIP. These muta
tions included small deletions and insertions, point mutations and RNA
splice junction alterations and resulted in the half normal activity
of both the erythroid specific and house keeping isozymes. Most AIP mu
tations were private; however, certain mutations were frequently found
in Dutch (R116W) and Swedish (W198X) AIP families. A variant form of
AIP, in which patients have normal erythroid activity, but half-normal
activity of the housekeeping isozyme, resulted from two mutations at
the exon 1/intron 1 boundary, each altering splicing of the hepatic sp
ecific transcript. In addition, 10 polymorphisms in the HMB synthase g
ene have been identified that are useful for the diagnosis of presympt
omatic AIP heterozygotes in families whose specific mutations have not
been determined. (C) 1994 Wiley-Liss, Inc.